Endurant Stent Graft System vs Excluder Endoprothesis: ADVANCE Trial
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 600 participants.
Also called NCT05378347
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 600 participants
- Sponsor
- Registry
-
NCT05378347
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States, Finland, France, Germany, Greece, Italy, Japan, Netherlands, Spain, Switzerland, Taiwan, United Kingdom
- Registry status
- Recruiting
Technical summary
Registry record NCT05378347. Randomized; single masking; primary purpose treatment. Start 2023-01-05 (actual); primary completion 2027-05 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Endurant Stent Graft System vs Excluder Endoprothesis: ADVANCE Trial
- Acronym
- ADVANCE
- Condition
- Abdominal Aortic Aneurysm
- Condition
- Abdominal Aortic Aneurysm >= 5.5 Centimeters in Male (Disorder)
- Condition
- Abdominal Aortic Aneurysm >= 5.0 Centimeters in Female (Disorder)
- Intervention (Device)
- Medtronic Endurant II or Endurant IIs Stent Graft System
- Intervention (Device)
- Gore Excluder or Gore/ Excluder Conformable AAA Endoprosthesis
- Lead sponsor
- Medtronic Cardiovascular
Record details
- Record id
cardio:ct-nct05378347- Content hash
c0259096530b37ba8e45d6fad5e018dd3de799f83e13a4e765d89522439efa96